The discovery phase in drug development requires rapid and reliable data in making key decisions for investigations that may range from proof-of-concept to drug candidate selection. Therefore, the criteria used in discovery are based on specific needs of the Sponsor.
KCAS has a significant infrastructure in LC-MS/MS method development and leverages that infrastructure to provide high quality with rapid turnaround time. In achieving this, we utilize a fit for purpose acceptance criteria and qualification experimental design, along with a peer reviewed reporting system.
KCAS is chosen in vast majority of cases because of (1) the quality of data we provide, (2) the deep expertise we have as part of our infrastructure guiding our method development efforts, (3) a client focused approach to work, and (4) our successful track record of taking on challenging projects.
Info/Fact Sheet: Download PDF